CORT makes pipeline progress with the submission of a new drug application for relacorilant to treat patients with endogenous hypercortisolism. REDWOOD CITY, Calif., December 30, 2024--Corcept ...
All products are independently selected by our editors. If you buy something, we may earn an affiliate commission. Moving into the blank white box of a new apartment is simultaneously thrilling ...